Additionally, tumours with a high expression of FTH1 and IDO1 may be particularly susceptible to combination strategies involving ferroptosis inducers and immune checkpoint inhibitors, offering a potential avenue for targeted therapy. The gene discussed is IDO1; the disease is neoplasm.